Some studies show as many as 15% of participants experiencing some form of shedding while on a GLP-1, while other research acknowledges that evidence supporting any sort of causative relationship as sparse and conflicting. Whats happening here
Treatment discontinuation due to side effects occurred in 4.3%, 7.1%, 6.2%, and 2.6% of participants in the 5, 10, 15 mg, and placebo groups, respectively [18]
Ask for certificates of analysis, confirm the pharmacy or lab source, and favor clinicians who share transparent sourcing and dosing rationales
At Prime Body Solutions, every program is designed and managed by Dr
In contrast, natural GLP-1 has no therapeutic applications as an administered medication due to its pharmacokinetic limitations